[1] U. H. Ehling, R.B. Cumming, and H. V. Malling, Mutation Research, 5, 1968, 417-428
[2] G. L. Petzold and J. A. Swenberg, Cancer Research, 38, 1978, 1589
[3] R. D. Synder and J. D. Regan, Mutation Research, 91, 1981, 307
[4] G. A. Sega, A. E. Sluder, L. S. McCoy, J. G. Ownens and E. E. Generoso, 159, 1986, 55
[5] H. G. Ramjit, M. M. Singh and A. B. Codington, Journal of Mass spectroscopy, 31, 1996, 867
[6] G. Colli, D. Mauleon and J. Vessman, Pharmeuropa, 12, 2000, 401
[7] P. Leigh and M. Bowker, Pharmeuropa, 12, 2000, 734
[8] C.R. Lee, F. Guivarch, C. N. Vandau, D. Tessier and A. M. Krstulovic, International journal of pharmaceutics, 195, 2000, 159
[9] C.R. Lee, F. Guivarch, C. N. Vandau, D. Tessier and A. M. Krstulovic, Analyst, 128, 2003, 857
[10] ICH Q2 (R1), Validation of analytical procedures: Text and Methodology, Fed. Reg (19 May 1997) 62:27463